Drugs affecting blood coagulation, platelet aggregation, fibrinolysis Flashcards
Fibrinoytic drugs are used to treat…
- are used to treat cardiovascular thrombosis
Heparin inhibits action of _______
inhibits action of thrombin, Factors X & IX
Which of the following drugs interferes with the COX enzyme?
- Warfarin
- Aspirin
- Aprotonin
- Heparin
Aspirin
Haemostasis is
A delicate balance between the normal function of blood and preventing blood loss following vessel damage
What is a thrombosis ?
Formation of a thrombus (blood clot) within a vessel
Initiated by:
pooling of blood in veins due to sluggish flow (e.g. DVT in calf after long flights)
what is an embolus?
Fragment or whole thrombus detached from blood vessel wall
Travels through blood vessels
Blocks small blood vessels in pulmonary, cardiac, CNS circulation
pulmonary embolism (PE) myocardial infarction (MI) stroke
Targets for modifying thrombosis process?
Modify coagulation
most successful in venous thrombosis
Modify platelet aggregation
important in arterial thrombosis
Modify clot, thrombus breakdown
after prophylaxis fails
Inhibit thrombus formation
without _____ _______.
Inhibit thrombus formation
without
Preventing haemostasis
what is the action of heparin?
Activates ANTITHROMBIN (AT)
Activated AT forms complexes with activated clotting factors: THROMBIN, Factors Xa (and FIXa & XIa to a lesser extent) inactivating them
Heparins increase :
- rate of complex - formation
What are the problems with heparin?
Poorly absorbed from oral administration
Give intravenously or subcutaneously
Risk of haemorrhage
Mild: cease administration
Severe: protamine sulphate- forms complex with heparin, no longer has anticoagulant effect
What is the orally anticoagulant?
Warfarin
What are the actions of Warfarin ?
Mechanism of Action. Warfarin acts by inhibiting the synthesis of vitamin K-dependent clotting factors, which include Factors II, VII, IX, and X, and the anticoagulant proteins C and S. Vitamin K is an essential cofactor for the post ribosomal synthesis of the vitamin K-dependent clotting factors
What are the problems of Warfarin?
+Slow onset
- Pre-existing factors need to be depleted
- Variation in half-life between clotting factors
- After administration patient is only fully anticoagulated after 3 days (starting regimen)
+Activity influenced by Vitamin K
+Many interactions: drugs, foods etc
+Risk of haemorrhage
Avoid in late pregnancy, haemorrhage in newborn
+Teratogenic
Avoid in early pregnancy